Pfizer Inc (PFE)

Quick ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash US$ in thousands 2,853,000 416,000 1,944,000 1,786,000 1,121,000
Short-term investments US$ in thousands 19,674,000 44,632,000 58,250,000 10,437,000 8,525,000
Receivables US$ in thousands 11,177,000 10,952,000 11,479,000 7,930,000 8,724,000
Total current liabilities US$ in thousands 47,794,000 42,138,000 42,671,000 25,920,000 37,304,000
Quick ratio 0.71 1.33 1.68 0.78 0.49

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($2,853,000K + $19,674,000K + $11,177,000K) ÷ $47,794,000K
= 0.71

The quick ratio of Pfizer Inc. has exhibited fluctuations over the past five years. In 2023, the quick ratio decreased to 0.69 from 1.00 in 2022, indicating a weakened ability to cover immediate liabilities with highly liquid assets. Compared to 2021 and 2020, where the quick ratio was 1.19 and 1.04 respectively, the current liquidity position seems relatively weaker. However, it is worth noting that the quick ratio has improved significantly since 2019 when it stood at 0.66, suggesting enhanced liquidity management by Pfizer in recent years. Overall, the downward trend in the quick ratio from 2022 to 2023 may raise concerns about Pfizer's short-term liquidity position and ability to meet its short-term obligations with liquid assets.


Peer comparison

Dec 31, 2023


See also:

Pfizer Inc Quick Ratio